As of 2026-02-02, the Relative Valuation of CVS Health Corp (CVS) is 43.50 USD. This relative valuation is based on P/E multiples. With the latest stock price at 74.52 USD, the upside of CVS Health Corp based on Relative Valuation is -41.6%.
The range of the Relative Valuation is 7.99 - 84.44 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 26.0x | 23.8x |
| Forward P/E multiples | 18.4x - 21.7x | 20.1x |
| Fair Price | 7.99 - 84.44 | 43.50 |
| Upside | -89.3% - 13.3% | -41.6% |
| Date | P/E |
| 2026-01-30 | 201.70 |
| 2026-01-29 | 201.48 |
| 2026-01-28 | 200.38 |
| 2026-01-27 | 194.88 |
| 2026-01-26 | 227.01 |
| 2026-01-23 | 224.68 |
| 2026-01-22 | 223.79 |
| 2026-01-21 | 220.57 |
| 2026-01-20 | 216.78 |
| 2026-01-16 | 212.74 |
| 2026-01-15 | 220.21 |
| 2026-01-14 | 214.72 |
| 2026-01-13 | 218.37 |
| 2026-01-12 | 217.51 |
| 2026-01-09 | 217.35 |
| 2026-01-08 | 218.16 |
| 2026-01-07 | 215.97 |
| 2026-01-06 | 218.43 |
| 2026-01-05 | 217.67 |
| 2026-01-02 | 216.89 |
| 2025-12-31 | 214.80 |
| 2025-12-30 | 216.13 |
| 2025-12-29 | 216.59 |
| 2025-12-26 | 215.48 |
| 2025-12-24 | 214.15 |
| 2025-12-23 | 211.23 |
| 2025-12-22 | 212.09 |
| 2025-12-19 | 210.36 |
| 2025-12-18 | 210.55 |
| 2025-12-17 | 210.80 |
| 2025-12-16 | 211.91 |
| 2025-12-15 | 215.69 |
| 2025-12-12 | 214.96 |
| 2025-12-11 | 218.78 |
| 2025-12-10 | 213.75 |
| 2025-12-09 | 211.77 |
| 2025-12-08 | 207.14 |
| 2025-12-05 | 204.71 |
| 2025-12-04 | 207.74 |
| 2025-12-03 | 203.00 |
| 2025-12-02 | 210.09 |
| 2025-12-01 | 214.10 |
| 2025-11-28 | 217.51 |
| 2025-11-26 | 216.15 |
| 2025-11-25 | 212.39 |
| 2025-11-24 | 210.85 |
| 2025-11-21 | 211.20 |
| 2025-11-20 | 205.82 |
| 2025-11-19 | 207.20 |
| 2025-11-18 | 210.96 |